Glucuronidation of SN-38, the active metabolite of irinotecan, by human hepatic microsomes

Pharmacology and Toxicology

Volumn 80, Issue 2, 1997, Pages 91-96

  Haaz, Marie Christine ^a   Rivory, Laurent ^a   Jantet, Sophie ^a   Ratanasavanh, Damrong ^a   Robert, Jacques ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AMIKACIN; CEFTRIAXONE; CHOLIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; DETERGENT; DIGITONIN; DRUG METABOLITE; FLUOROURACIL; IRINOTECAN; LOPERAMIDE; METOCLOPRAMIDE; MORPHINE; ONDANSETRON; PARACETAMOL; POLIDOCANOL; TRITON X 100; TROLEANDOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

EID: 0031058320     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00289.x     Document Type: Article

References (17)

1. Akimoto, K., A. Kawai & K. Ohya: Kinetic studies of the hydrolysis and lactonization of camptothecin and its derivatives, CPT-11 and SN-38, in aqueous solution. Chem. Pharm. Bull. 1994, 42, 2135-2138.
2. Albin, N., L. Massaad, C. Toussaint, M.C. Mathieu, J. Morizet, O. Parise, A. Gouyette & G. G. Chabot: Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res. 1993, 53, 3541-3546.
3. Berthou, F., D. Ratanasavanh, C. Riché, D. Picard, T. Voisin & A. Guillouzo: Comparison of caffeine metabolism by slices, microsomes, and hepatocyte cultures from adult human liver. Xenobiotica, 1989, 19, 401-407.
4. Brunelle, F. & R. K. Verbeeck: Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal β-glucuronidase activity. Biochem. Pharmacol. 1993, 46, 1953-1958.
5. Dutton, G. J.: Glucuronidation of drugs und other compounds. CRC Press, Boca Raton, FL, 1980.
6. Gupta, E., T. M. Lestingi, R. Mick, J. Ramirez, E. V. Vokes & M. J. Ratain: Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res. 1994, 54, 3723-3725.
7. Hazelton, G. A. & C. D. Klaassen: UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside. Differences in activation and induction properties in rat and mouse liver. Drug Metab. Dispos. 1988, 16, 30-36.
8. Kawato, Y., M. Aonuma, Y. Hirota, H. Kuga & K. Sato: Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 1991, 51, 4187-4191.
9. Mulder, G. J.: Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 1992, 32, 25-49.
10. Pommier, Y.: Eukaryotic DNA topoisomerase I : genome gatekeeper and its intruders, camptothecins. Semin. Oncol. 1996, 23 (suppl. 3), 3-10.
11. Rivory, L. P. & J. Robert: Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma. J. Chromatogr. 1994, 661B, 133-141.
12. Rivory, L. P. & J. Robert: Identification and kinetics of a β-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan. Cancer Chemother. Pharmacol. 1995, 36, 176-179.
13. Rivory, L. P., P. Canal, E. Chatelut, A. Mathieu-Boué & J. Robert: Kinetics of the interconversion of the carboxylate and lactone forms of irinotecan (CPT-11) and of its metabolite SN-38 in patients. Cancer Res. 1994, 54, 6330-6333.
14. Rivory, L. P., P. Canal, F. Lokiec, J. P. Armand, E. Chatelut, A. Mathieu-Boué & J. Robert: Inter-relationships of the pharmacokinetics of SN-38 and its β-glucuronide in patients treated with irinotecan (CPT-11). Proc. Am. Assoc. Cancer Res. 1995, 36, 233.
15. Rougier, P. & R. Bugat: CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile. Symin. Oncol. 1996, 23 (suppl. 3), 34-41.
16. Takasuna, K., Y. Kasia, Y. Kitano, K. Mori, R. Kobayashi, T. Hagiwara, K. Kakihata, M. Hirohashi, M. Nomura, E. Nagai & T. Kamataki: Protective effects of Kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinoteca hydrochloride (CPT-11), in rats. Jap. J. Cancer Res. 1995, 86, 978-984.
17. Zakim, D. & D. A. Vessey: The properties of undine diphosphate glucuronyltransferase(s) which catalyse the synthesis of steroid glucuronides in microsomal fractions from guinea-pig liver. Biochem. J. 1976, 157, 667-680.